Cited by 237MicroRNA in disease regulationCancer-related molecular mechanisms researchLung Cancer Research Studies

MiR-21 overexpression in human primary squamous cell lung carcinoma is associated with poor patient prognosis

Open access
Gao, Wen, Shen, Hua, Liu, Lingxiang, Xu, Jian, Xu, Jing, Shu, Yongqian·2011·Journal of Cancer Research and Clinical Oncology

Abstract

Purpose This study compared miRNA expression patterns in primary squamous cell lung carcinoma specimens with those of matched normal lung tissue in order to determine their potential relevance to clinicopathological factors and patient postoperative survival times. Methods Locked nucleic acids miRNA microarray expression profiling was performed on four matched pairs of tissues. After microarray validation by quantitative real-time reverse transcription polymerase chain reaction assays (qRT-PCR) (real-time PCR), miR-21 was selected for further TaqMan real-time PCR study in 30 matched tissue pairs. Results Seven miRNAs of hsa-miR-21, hsa-miR-31, hsa-miR-34a, hsa-miR-22*, hsa-miR-504, hsa-miR-18a, and hsa-miR-412 were observed to be upregulated greater than twofold in the squamous cell lung carcinoma tissues compared with normal tissues, whereas 23 miRNAs of hsa-miR-30a, hsa-miR-30d, hsa-miR-126, hsa-miR-652, hsa-miR-100, hsa-miR-143, hsa-miR-130a, hsa-miR-145, hsa-miR-30e, hsa-miR-126*, hsa-miR-181a, hsa-miR-125b, hsa-miR-886-3p, hsa-miR-451, hsa-miR-29c, hsa-miR-26b, hsa-miR-101, hsa-miR-320, hsa-miR-30b, hsa-miR-886-5p, hsa-miR-29a, hsa-miR-26a, and hsa-miR-99a were found to be downregulated greater than twofold. MiR-21 was overexpressed in 73.3% of the squamous cell lung carcinoma specimens examined (P = 0.022). The relationship between the miR-21 expression level and various clinicopathologic factors was also analyzed. High-level expression of miR-21 was significantly correlated with shortened survival time (P = 0.022, log-rank test; Kaplan-Meier). Multivariate Cox proportional hazard regression analysis revealed this significant prognostic impact (P = 0.000; HR 1.293; 95% CI 1.123-1.489) to be independent of clinical disease stage (P = 0.013; HR 2.660; 95% CI 1.229-5.758) and other clinicopathologic factors. Conclusions Expression patterns of miRNAs were found to be systematically altered in squamous cell lung carcinoma tissue. High miR-21 expression is associated with shortened survival time, indicating that miR-21 may serve as a molecular diagnostic and prognostic marker for patients with squamous cell lung carcinoma.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s00432-010-0918-4

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Population-specific genetic and environmental factors may influence miR-21 expression, leading to variations in diagnostic performance and prognostic utility.

    “Addressing this gap is crucial, as population-specific genetic and environmental factors may influence microRNA e.g.miR-21 expression, leading to variations in the diagnostic performance and prognostic utility as well as therapeutic response [14,15].”

    From miR-21 as a diagnostic and prognostic biomarker in glioma: tissue and serum expression analysis in a Pakistani cohort (2026) · cites this paper as [15]

    The Discussion reports that miR-21 has different diagnostic and prognostic implications across cancer types and suggests that specimen origin or individual patient variation may explain discrepancies in miRNA profiles. It does not identify population-specific genetic or environmental factors as causes of miR-21 expression differences, or show that such factors change diagnostic performance or prognostic utility across populations. Page numbers are not available in our copy. (LLM, conf=0.82)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 3

  1. Gao W, Yu Y, Cao HL, Shen H, Li XD, Pan SY, Shu YQ (2010) Deregulated expression of miR-21,miR-143 and miR-181a in non small cell lung cancer is related to clinicopathologic characteristics or patient prognosis. Biomed Pharmacother (in press, accepted on Jan 29, 2010)
  2. Greene FL, Page DL, Fleming ID et al (2002) AJCC cancer staging handbook-TNM classi W cation of malignant tumors, 6th edn. Springer, New York
  3. Sobin LH, Wittekind C (2002) UICC TNM classi W cation of malignant tumours, 6th edn. Wiley, New York

Cited by

Sorted by citations

Authors
Gao, W., Shen, H., Liu, L., Xu, J., Xu, J., & Shu, Y.
Affiliations
Jiangsu Province Hospital (CN)
Corresponding author
Shu, Yongqian
Venue
Journal of Cancer Research and Clinical Oncology
Published
2010-05-28
Volume
137
Issue
4
Pages
557-566
ISSN
  • 0084-5353 (ISSN-L)
  • 0171-5216
  • 1432-1335
OpenAlex
W2006535551
Cited by
237
References
2
Citations by year
2026: 2 · 2025: 4 · 2024: 5 · 2023: 11 · 2022: 7 · 2021: 5 · 2020: 11 · 2019: 12 · 2018: 8 · 2017: 16 · 2016: 17 · 2015: 25 · 2014: 36 · 2013: 27 · 2012: 27
FWCI
7.76
Type
journal article
Language
en
Open access
Locations
  • Journal of Cancer Research and Clinical Oncology (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › MicroRNA in disease regulation
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer-related molecular mechanisms research
  • Health Sciences › Medicine › Oncology › Lung Cancer Research Studies
Keywords
lung squamous cell carcinoma, miRNA expression profiling, prognostic factors, postoperative survival, clinicopathological features, miR-31, miR-34a, miR-22, miR-504, miR-18a, miR-30a, miR-126, miR-652, miR-100, miR-143
MeSH terms
Carcinoma, Squamous Cell, Humans, Lung Neoplasms, Prognosis, Quality Control, Biomarkers, Tumor, Polymerase Chain Reaction, RNA-Binding Proteins, Oligonucleotide Array Sequence Analysis, MicroRNAs, Apoptosis Regulatory Proteins

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review